BS

Brajbhan Singh

Active Director Additional Director DIN 11039941
DIN 11039941 First appointment Apr 2025 Primary industry Printing & Publishing
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Brajbhan Singh

Data last updated:

Brajbhan Singh is an Additional Director at Pellicle Studios Private Limited (since 2025) and Additional Director at Ausius Pharmaceuticals Private Limited (since 2025). The companies operate in Printing & Publishing and Healthcare.

DIN 11039941
Primary Designation Additional Director
Industry Printing & Publishing
First Appointment 05 Apr 2025
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pellicle Studios Private Limited U22100DL2018PTC330711
Additional Director25 Aug 20252018Active
Additional Director05 Apr 20252021Active

Board colleagues of Brajbhan Singh

Directorship timeline

Open interactive timeline →
Pellicle Studios Private Limited
Ausius Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Brajbhan Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Brajbhan Singh

Brajbhan Singh currently holds 2 directorships: Pellicle Studios Private Limited (Additional Director, since 25 Aug 2025); Ausius Pharmaceuticals Private Limited (Additional Director, since 05 Apr 2025).

Brajbhan Singh was first appointed on 05 Apr 2025 as Additional Director at Ausius Pharmaceuticals Private Limited.

The current boards of Brajbhan Singh's companies include Divya Chaurasia (Pellicle Studios Private Limited), Nishant Nagpal (Pellicle Studios Private Limited), Utkarsh Arun (Pellicle Studios Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available